Global Oncology Information Systems Market Size- By Products & Services, By Application, By End-User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Global Oncology Information Systems Market Introduction and Overview

According to SPER Market Research, the Global Oncology Information Systems Market is estimated to reach USD 2.13 billion by 2034 with a CAGR of 4.98%.

The report includes an in-depth analysis of the Global Oncology Information Systems Market, including market size and trends, product mix, Applications, and supplier analysis. The global Oncology Information Systems market was valued at USD 1.31 billion in 2024, and it is expected to rise at a 4.98% CAGR from 2025 to 2034. The growing adoption of advanced technologies, such as artificial intelligence and cloud-based platforms, enables more accurate diagnosis, treatment personalization, and streamlined workflows. Increasing integration of OIS with electronic health records (EHR) and radiotherapy equipment enhances operational efficiency and data management in hospitals and cancer care centres.

Additionally, the shift toward value-based care and precision oncology emphasizes the need for comprehensive systems that improve patient outcomes and reduce treatment errors. Expanding healthcare infrastructure, rising healthcare spending, and supportive government initiatives further boost market growth.

By Products & Services Insights

The solutions segment dominates the Oncology Information Systems (OIS) market, driven by software that maintains patient records, predicts treatment outcomes, and plans cancer treatment regimens. These solutions facilitate seamless information exchange across healthcare organizations, bridging practitioners and radiology centres, which enhances the safety and efficiency of cancer care. They also assist physicians and surgeons in selecting appropriate treatments, improving patient survival rates.

By Application Insights

The medical oncology segment leads the Oncology Information Systems (OIS) market, driven by its use of immunotherapy, chemotherapy, hormonal therapy, and targeted therapy, offering a comprehensive and effective approach to cancer treatment. The rising prevalence of cancer and increased adoption of these therapies are key factors fuelling market growth. Meanwhile, the surgical oncology segment is also expected to grow significantly, as cancer treatment increasingly combines surgery with multi-modal therapies such as radiotherapy, targeted molecular treatments, and chemotherapy. The growing complexity of surgical procedures and the need for multidisciplinary coordination among specialists drive the adoption of OIS in surgical oncology, supporting efficient treatment planning, communication, and improved patient outcomes.

By End-User Insights

The hospitals and diagnostic imaging centres segment dominate the Oncology Information Systems (OIS) market, as these facilities adopt OIS to streamline workflows, integrate multidisciplinary data, and enhance cancer treatment planning. By connecting oncologists, radiologists, and pathologists, OIS enables comprehensive patient data management, reduces errors, and improves operational efficiency. Integration with electronic health records (EHRs) minimizes redundant testing and optimizes resource utilization. As hospitals expand radiation oncology services and seek cost-effective cancer care solutions, demand for OIS continues to grow. Meanwhile, ablation and cancer care centres are expected to register the fastest growth, leveraging OIS to integrate real-time imaging, ablation devices, and patient data for precise tumour targeting, improving procedural accuracy and treatment outcomes.

Regional Insights

North America leads the Oncology Information Systems (OIS) market, holding the largest revenue share in 2024. The region's adoption is driven by the growing need for efficient, precise, and advanced cancer treatment and care solutions. Factors supporting this growth include well-developed healthcare infrastructure, the presence of leading cancer research institutions, substantial healthcare spending, high patient disposable incomes, and a strong reimbursement framework. These elements collectively facilitate the widespread implementation of OIS, enabling hospitals and cancer care centres to streamline workflows, integrate multidisciplinary data, and improve treatment planning and patient outcomes, solidifying North America's dominant position in the global market.

Market Competitive Landscape

The Oncology Information Systems (OIS) market, competition is intense among leading companies such as Elekta AB, Varian Medical System, RaySearch Laboratories, Accuray Incorporated, Cerner Corporation, Philips Healthcare, Flatiron Health, and BrainLab. These firms compete primarily on technological innovation, product portfolio breadth, and integration capabilities.

Companies like Varian and Elekta focus on advanced radiotherapy planning and precision oncology solutions, while RaySearch Laboratories and BrainLab emphasize workflow automation and software interoperability. Philips, Cerner, and Oracle compete on hospital-wide integration, cloud-based solutions, and electronic health record (EHR) connectivity. Other factors influencing competition include pricing strategies, regulatory compliance, global presence, customer support, and strategic partnerships or acquisitions aimed at expanding market share and entering emerging regions.

Scope of the report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Products & Services, By Application, By End User

Regions covered North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered Accuray Incorporated, BrainLab, DOSIsoft SA, Elekta, FLATIRON HEALTH, Koninklijke Philips N.V, Oracle (Cerner Corporation), RaySearch Laboratories, Varian Medical Systems, Inc.

Key Topics Covered in the Report

Global Oncology Information Systems Market Size (FY'2021-FY'2034)

Overview of Global Oncology Information Systems Market

Segmentation of Global Oncology Information Systems Market By Products & Services (Software, Services)

Segmentation of Global Oncology Information Systems Market By Application (Medical Oncology, Radiation Oncology, Surgical Oncology)

Segmentation of Global Oncology Information Systems Market By End-user (Hospitals & Diagnostic Imaging Centres, Ablation Care Centres and Cancer Care Centres, Research Facilities)

Statistical Snap of Global Oncology Information Systems Market

Expansion Analysis of Global Oncology Information Systems Market

Problems and Obstacles in Global Oncology Information Systems Market

Competitive Landscape in the Global Oncology Information Systems Market

Details on Current Investment in Global Oncology Information Systems Market

Competitive Analysis of Global Oncology Information Systems Market

Prominent Players in the Global Oncology Information Systems Market

SWOT Analysis of Global Oncology Information Systems Market

Global Oncology Information Systems Market Future Outlook and Projections (FY'2025-FY'2034)

Recommendations from Analyst